Dr. Thomas Fogarty is the Founder and serves as Director at Fogarty Institute for Innovation. He is a Co-Founder and serves as a Managing Director at Emergent Medical Partners. He also serves as a Board Member at Avinger. He also serves as a Board Member of BioTrace Medical. He is a Co-Founder of Biopsys Medical. He has been involved with a wide spectrum of innovations in business and technology, serving as founder/co-founder, and Chairman/board member of over 30 medical device companies, the majority based on devices designed and developed by Fogarty Engineering, Inc. Dr. Fogarty has published approximately 180 scientific articles and textbook chapters in fields of general and cardiovascular surgery, and is the author or co-author of more than 125 patents and patent applications. His patents include the "industry standard" Fogarty balloon embolectomy catheter (now owned by Edwards Lifesciences), and the widely used Aneurx Stent Graft (now owned by Medtronic). Dr. Fogarty is the recipient of countless awards and honors; most significantly, he is the recipient of the Jacobson Innovation Award of the American College of Surgeons, the 2000 Lemelson-MIT prize for Invention and Innovation and was inducted into the Inventors Hall of Fame in December 2001. Dr. Fogarty is currently Clinical Professor of Surgery at Stanford University. Previously, he has held positions as President, Medical Staff at Stanford University Medical Center, and Director, Cardiovascular Surgery at Sequoia Medical Center. He was also the Founder of Vascular Architects. Dr. Fogarty was born in Cincinnati, Ohio and received his undergraduate education at Xavier University and his medical degree from the University of Cincinnati. He completed his residency at the University of Oregon. Dr. Fogarty was a founder and general partner of Three Arch Partners, and a general partner in five successive Three Arch venture funds.